Moline M - Search Results

1

Evidence-based insomnia treatment strategy using novel orexin antagonists: A review.

Kishi T, Nishida M, Koebis M, Taninaga T, Muramoto K, Kubota N, Moline M, Sakuma K, Okuya M, Nomura I, Iwata N. Kishi T, et al. Among authors: moline m. Neuropsychopharmacol Rep. 2021 Dec;41(4):450-458. doi: 10.1002/npr2.12205. Epub 2021 Sep 23. Neuropsychopharmacol Rep. 2021. PMID: 34553844 Free PMC article. Review.

2

Long-term efficacy and tolerability of lemborexant compared with placebo in adults with insomnia disorder: results from the phase 3 randomized clinical trial SUNRISE 2.

Kärppä M, Yardley J, Pinner K, Filippov G, Zammit G, Moline M, Perdomo C, Inoue Y, Ishikawa K, Kubota N. Kärppä M, et al. Among authors: moline m. Sleep. 2020 Sep 14;43(9):zsaa123. doi: 10.1093/sleep/zsaa123. Sleep. 2020. PMID: 32585700 Free PMC article. Clinical Trial.

3

Efficacy and safety of lemborexant in adults with insomnia: comparing Japanese and non-Japanese subgroups from the global, phase 3, randomized, double-blind, placebo-controlled SUNRISE 2 study.

Inoue Y, Watanabe T, Takashima S, Takase T, Ishikawa K, Kubota N, Yardley J, Moline M. Inoue Y, et al. Among authors: moline m. J Clin Sleep Med. 2021 May 1;17(5):1067-1074. doi: 10.5664/jcsm.9148. J Clin Sleep Med. 2021. PMID: 33576735 Free PMC article. Clinical Trial.

4

Long-term effectiveness and safety of lemborexant in adults with insomnia disorder: results from a phase 3 randomized clinical trial.

Yardley J, Kärppä M, Inoue Y, Pinner K, Perdomo C, Ishikawa K, Filippov G, Kubota N, Moline M. Yardley J, et al. Among authors: moline m. Sleep Med. 2021 Apr;80:333-342. doi: 10.1016/j.sleep.2021.01.048. Epub 2021 Feb 1. Sleep Med. 2021. PMID: 33636648 Free article. Clinical Trial.

5

Safety and Efficacy of Lemborexant in Patients With Irregular Sleep-Wake Rhythm Disorder and Alzheimer's Disease Dementia: Results From a Phase 2 Randomized Clinical Trial.

Moline M, Thein S, Bsharat M, Rabbee N, Kemethofer-Waliczky M, Filippov G, Kubota N, Dhadda S. Moline M, et al. J Prev Alzheimers Dis. 2021;8(1):7-18. doi: 10.14283/jpad.2020.69. J Prev Alzheimers Dis. 2021. PMID: 33336219 Clinical Trial.

6

Population Pharmacokinetics and Exposure-Response Analyses for the Most Frequent Adverse Events Following Treatment With Lemborexant, an Orexin Receptor Antagonist, in Subjects With Insomnia Disorder.

Lalovic B, Majid O, Aluri J, Landry I, Moline M, Hussein Z. Lalovic B, et al. Among authors: moline m. J Clin Pharmacol. 2020 Dec;60(12):1642-1654. doi: 10.1002/jcph.1683. Epub 2020 Jul 14. J Clin Pharmacol. 2020. PMID: 32666570 Free PMC article.

7

Efficacy and safety of lemborexant over 12 months in Asian adults with insomnia disorder.

Dash A, Pinner K, Inoue Y, Hayashida K, Lim SC, Yun CH, Lan TH, Huang CL, Yardley J, Kubota N, Moline M. Dash A, et al. Among authors: moline m. Sleep Med X. 2022 Mar 24;4:100044. doi: 10.1016/j.sleepx.2022.100044. eCollection 2022 Dec. Sleep Med X. 2022. PMID: 35402894 Free PMC article.

8

Lemborexant, A Dual Orexin Receptor Antagonist (DORA) for the Treatment of Insomnia Disorder: Results From a Bayesian, Adaptive, Randomized, Double-Blind, Placebo-Controlled Study.

Murphy P, Moline M, Mayleben D, Rosenberg R, Zammit G, Pinner K, Dhadda S, Hong Q, Giorgi L, Satlin A. Murphy P, et al. Among authors: moline m. J Clin Sleep Med. 2017 Nov 15;13(11):1289-1299. doi: 10.5664/jcsm.6800. J Clin Sleep Med. 2017. PMID: 29065953 Free PMC article. Clinical Trial.

9

Effect of severe renal impairment on pharmacokinetics, safety, and tolerability of lemborexant.

Landry I, Aluri J, Hall N, Filippov G, Dayal S, Moline M, Reyderman L. Landry I, et al. Among authors: moline m. Pharmacol Res Perspect. 2021 Apr;9(2):e00734. doi: 10.1002/prp2.734. Pharmacol Res Perspect. 2021. PMID: 33689224 Free PMC article. Clinical Trial.

10

Evaluation of SAMP8 Mice as a Model for Sleep-Wake and Rhythm Disturbances Associated with Alzheimer's Disease: Impact of Treatment with the Dual Orexin (Hypocretin) Receptor Antagonist Lemborexant.

Beuckmann CT, Suzuki H, Musiek ES, Ueno T, Sato T, Bando M, Osada Y, Moline M. Beuckmann CT, et al. Among authors: moline m. J Alzheimers Dis. 2021;81(3):1151-1167. doi: 10.3233/JAD-201054. J Alzheimers Dis. 2021. PMID: 33843668 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

162 results

Search Page